Paroxetine exposure during pregnancy and cardiac malformations.
Scialli
Anthony R
AR
Tetra Tech Sciences, Arlington, Virginia 22201-3397, USA. ascialli@sciences.com
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology / Q000209:etiology*; D000818:Animals; D003627:Data Interpretation, Statistical; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005260:Female; D006330:Heart Defects, Congenital / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D015201:Meta-Analysis as Topic; D051379:Mice; D016017:Odds Ratio; D017374:Paroxetine / Q000009:adverse effects*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011817:Rabbits; D051381:Rats; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013045:Species Specificity; D035501:Uncertainty
D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors